NCT00551317View on ClinicalTrials.gov

A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Atherosclerosis

Interventions

DRUG

Darapladib (SB480848)

Trial Locations (1)

96813

GSK Investigational Site, Honolulu

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY